PharPoint is offering 1 hour of complimentary clinical trial consulting!

PharPoint Research is opening its doors to you for a private session – to meet and engage our award winning team of clinical trial consultants in Clinical Operations, Data Management and Biostatistics. Space is limited, so please sign up through the registration form below and we will contact you to confirm the time of your appointment, topic of your consulting needs, and to discuss confidentiality requirements.
About PharPoint Research

From study design through product launch, PharPoint provides strategic and operational consulting to the bio-pharmaceutical and medical device industries. Our experienced development teams have planned and conducted hundreds of clinical trials across numerous therapeutic areas. Compliments of PharPoint, we invite your clinical development team to engage PharPoint’s experts in a discussion regarding project activities, such as (but not limited to) protocol design, global investigative site planning, and data standardization.

A broader list of consulting services is illustrated below and on the following link. Your session will cover one hour, after completing a mutual non-disclosure agreement. Why are we offering our time and expertise for free? Simply, PharPoint Research wishes to share its appreciation, professional support, and scientific commitment to the North Carolina bio-pharmaceutical community, our valued customers.
Fields marked with an * are required
Clinical Trial Consulting

Meet Your PharPoint Consultants

Jennifer L. Bruce
Director of Clinical Operations
Jenny Bruce of PharPoint
Jenny has over 20 years of academic/industry experience, involving preclinical pharmacology and clinical research. Her clinical experience includes work within biotech, large pharma and CRO environments.
In the clinical arena, her work has included the implementation and management of global Phase I – IV studies, particularly large pivotal Phase II/III studies. She has functioned as Assistant and Associate Director of Clinical Research and Director of Project Management where she was responsible for the operational success of large global, multidisciplinary teams. She historically served as a clinical consultant and clinical research associate monitoring Phase I-IIIb trials throughout the US, Canada and Europe. Her overall work has included various drug development programs with a large pharmaceutical client where she also served as the Liaison for Quality Issues and Training. Jenny has worked extensively in a number of therapeutic areas including oncology(FAK and BRAF pathway tumors, melanoma, TNBC, ovarian, prostate), dermatology, GI, CNS (pain, depression, SAD, ADHD, Alzheimer’s Disease), CV, orthopedics, Infectious disease (HIV, Hep B, Hep C) and respiratory.
Moya Hawkins
Director of Data Management
Ms. Hawkins has been in the CRO industry since 1995 managing Phase 1-4 clinical trials across both EDC and paper platforms including global, multilingual Phase 3-4 studies.
Her database experience includes serving on EDC steering committees within several companies, application validation and serving as a point person for the implementation of the transition from paper based studies to EDC studies several companies. She was an integral part of the Medrio implementation team at PharPoint Research and serves as a platform expert within the company. Ms. Hawkins’ extensive experience includes managing a multi-country, emergency use protocol, studies with special patient populations, and salvage therapy studies. Ms. Hawkins also serves on a committee and volunteers for the Society of Clinical Data Management which is a is a non-profit, international organization founded to advance the discipline of clinical data management.
Amy Flynt, PhD
Director of Biostatistics
Dr. Flynt received her Ph.D. in statistics from North Carolina State University.
For over thirteen years, she has worked in the pharmaceutical/biomedical industry for both a CRO and a pharmaceutical company where she has served as a lead statistician and provided statistical support for Phase 1-4 clinical trials, NDA submissions, and pharmaceutical industry-sponsored pregnancy registries. She has also provided FDA representation for her sponsors, served as a DMC statistician, and as a statistical consultant. Dr. Flynt joined PharPoint Research in its inaugural year to grow the biostatistics operations. Under her leadership, the PharPoint Research biostatistics group has grown 150%.
Jayme Swinson
Director of Programming
Mr. Swinson joined PharPoint Research as one of the company’s original members with the goal of establishing and leading the programming department.
He has been instrumental in defining and refining standard processes across functional areas and succeeded in orchestrating PharPoint Research’s implementation and accreditation of multiple EDC systems. He also oversees the daily operations of statistical and database programming activities. Mr. Swinson has over sixteen years of experience in the CRO industry providing both statistical analysis and clinical database programming support for Phase 1-4 clinical trials as well as patient registries. He has led multiple data standardization and warehousing projects, many of which comply with the industry accepted SDTM format. He has provided programming support and leadership for numerous NDAs, sNDA, IND safety updates and ISS/ISE analyses.